Martin Crook
Director/Miembro de la Junta en Cardior Pharmaceuticals GmbH .
Perfil
Martin Crook is currently a Director at Cardior Pharmaceuticals GmbH.
He obtained a doctorate degree from the University of Bristol in 2000, an undergraduate degree from the University of Lancaster in 1995, and a graduate degree from the University of Birmingham in 1996.
Cargos activos de Martin Crook
Empresas | Cargo | Inicio |
---|---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Director/Miembro de la Junta | - |
Formación de Martin Crook.
University of Lancaster | Undergraduate Degree |
University of Birmingham | Graduate Degree |
University of Bristol | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Martin Crook